메뉴 건너뛰기




Volumn 3, Issue 1, 1999, Pages 49-57

Immune escape mechanisms in malignant melanoma (Review)

Author keywords

CTL; HLA; Malignant melanoma; TAA; TAP

Indexed keywords

HLA ANTIGEN; LEUKOCYTE ANTIGEN; MELANOMA SPECIFIC ANTIGENS; MELANOMA-SPECIFIC ANTIGENS; TUMOR PROTEIN;

EID: 0032614551     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (34)

References (109)
  • 2
    • 0026470235 scopus 로고
    • The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients
    • Haffner AC, Garbe C, Burg G, Buttner P, Orfanos CE and Rassncr G: The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer 66: 856-861, 1992.
    • (1992) Br J Cancer , vol.66 , pp. 856-861
    • Haffner, A.C.1    Garbe, C.2    Burg, G.3    Buttner, P.4    Orfanos, C.E.5    Rassncr, G.6
  • 3
    • 0024543677 scopus 로고
    • Current therapy for malignant melanoma
    • Lcgha SS: Current therapy for malignant melanoma. Semin Oncol 16: 534-344, 1989.
    • (1989) Semin Oncol , vol.16 , pp. 534-1344
    • Lcgha, S.S.1
  • 6
    • 0030030347 scopus 로고    scopus 로고
    • Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncolosy Group Trial EST 1684
    • Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC and Blum RH: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncolosy Group Trial EST 1684. J Clin Oncol 14: 7-17, 1996.
    • (1996) J Clin Oncol , vol.14 , pp. 7-17
    • Kirkwood, J.M.1    Strawderman, M.H.2    Ernstoff, M.S.3    Smith, T.J.4    Borden, E.C.5    Blum, R.H.6
  • 7
    • 0028872965 scopus 로고
    • A multicenter phase II clinical trial using dacarbazine and continuous infusion of interleukin-2 in metastatic melanoma: Clinical data and immunomonitorinc
    • Dummer R, Gore M, Hancock B, Guillou P, Grobben H, Becker J, Oskam R, Dieleman J and Burg G: A multicenter phase II clinical trial using dacarbazine and continuous infusion of interleukin-2 in metastatic melanoma: clinical data and immunomonitorinc. Cancer 75: 1038-1044, 1995.
    • (1995) Cancer , vol.75 , pp. 1038-1044
    • Dummer, R.1    Gore, M.2    Hancock, B.3    Guillou, P.4    Grobben, H.5    Becker, J.6    Oskam, R.7    Dieleman, J.8    Burg, G.9
  • 8
    • 0025837770 scopus 로고
    • Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malicnant melanoma
    • Falkson CI, Falkson G and Falkson HC: Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malicnant melanoma. J Clin Oncol 9: 1403-1408, 1991.
    • (1991) J Clin Oncol , vol.9 , pp. 1403-1408
    • Falkson, C.I.1    Falkson, G.2    Falkson, H.C.3
  • 9
    • 0027395732 scopus 로고
    • Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines
    • Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S and Rosenberg SA: Differential expression of MAGE-1, -2, and -3 messenger RNA in transformed and normal human cell lines. Cancer Res 53: 5-8, 1993.
    • (1993) Cancer Res , vol.53 , pp. 5-8
    • Zakut, R.1    Topalian, S.L.2    Kawakami, Y.3    Mancini, M.4    Eliyahu, S.5    Rosenberg, S.A.6
  • 10
    • 0027958312 scopus 로고
    • Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumorinfiltrating lymphocytes
    • Bakker AB, Schreurs MW, De BA, Kawakami Y, Rosenberg SA, Adema GJ and Figdor CG: Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumorinfiltrating lymphocytes. J Exp Med 179: 1005-1009, 1994.
    • (1994) J Exp Med , vol.179 , pp. 1005-1009
    • Bakker, A.B.1    Schreurs, M.W.2    De, B.A.3    Kawakami, Y.4    Rosenberg, S.A.5    Adema, G.J.6    Figdor, C.G.7
  • 13
    • 0030472678 scopus 로고    scopus 로고
    • Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
    • Wang RF, Appella E, Kawakami Y, Kang X and Rosenberg SA: Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med 184: 2207-2216, 1996.
    • (1996) J Exp Med , vol.184 , pp. 2207-2216
    • Wang, R.F.1    Appella, E.2    Kawakami, Y.3    Kang, X.4    Rosenberg, S.A.5
  • 15
    • 0029057043 scopus 로고
    • Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
    • Ferrone S and Marincola FM: Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 16:487-494, 1995.
    • (1995) Immunol Today , vol.16 , pp. 487-494
    • Ferrone, S.1    Marincola, F.M.2
  • 18
    • 0025971498 scopus 로고
    • Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression
    • D'Urso CM, Wang ZG, Cao Y, Tatakc R, Zcff RA and Ferrone S: Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest 87:284-292, 1991.
    • (1991) J Clin Invest , vol.87 , pp. 284-292
    • D'Urso, C.M.1    Wang, Z.G.2    Cao, Y.3    Tatakc, R.4    Zcff, R.A.5    Ferrone, S.6
  • 19
    • 0027439697 scopus 로고
    • Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA
    • Wang Z, Cao Y, Albino AP, Zeff RA, Houghton A and Ferrone S: Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA. J Clin Invest 91: 684-692, 1993.
    • (1993) J Clin Invest , vol.91 , pp. 684-692
    • Wang, Z.1    Cao, Y.2    Albino, A.P.3    Zeff, R.A.4    Houghton, A.5    Ferrone, S.6
  • 20
    • 0025814580 scopus 로고
    • Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene
    • Maio M, Altomonte M, Tatake R, Zeff RA and Ferrone S: Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene. J Clin Invest 88: 282-289, 1991.
    • (1991) J Clin Invest , vol.88 , pp. 282-289
    • Maio, M.1    Altomonte, M.2    Tatake, R.3    Zeff, R.A.4    Ferrone, S.5
  • 21
    • 0026691106 scopus 로고
    • NK cells and T cells: Mirror imaces?
    • Versteeg R: NK cells and T cells: mirror imaces? Immunol Today 13: 244-247, 1992.
    • (1992) Immunol Today , vol.13 , pp. 244-247
    • Versteeg, R.1
  • 24
    • 0030891643 scopus 로고    scopus 로고
    • Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines
    • Thor Strafen P, Kirkin AF, Seremet T and Zeuthen J: Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines. Int J Cancer 70: 582-586, 1997.
    • (1997) Int J Cancer , vol.70 , pp. 582-586
    • Thor Strafen, P.1    Kirkin, A.F.2    Seremet, T.3    Zeuthen, J.4
  • 25
    • 0027235705 scopus 로고
    • Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens
    • Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S and Ferrone S: Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res 53: 3349-3354, 1993.
    • (1993) Cancer Res , vol.53 , pp. 3349-3354
    • Kageshita, T.1    Wang, Z.2    Calorini, L.3    Yoshii, A.4    Kimura, T.5    Ono, T.6    Gattoni-Celli, S.7    Ferrone, S.8
  • 26
    • 0030020784 scopus 로고    scopus 로고
    • Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma
    • Luboldt HJ, Kubens BS, Rubben H and Grosse-Wilde H: Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma. Cancer Res 56: 826-830, 1996.
    • (1996) Cancer Res , vol.56 , pp. 826-830
    • Luboldt, H.J.1    Kubens, B.S.2    Rubben, H.3    Grosse-Wilde, H.4
  • 29
    • 0031963115 scopus 로고    scopus 로고
    • Comparative analysis of the in vivo expression of tyrosinase, Mart-1/Melan-a, and gp100 in metastatic melanoma lesions - Implications for immunotherapy
    • Cormier JN, Abati A, Fetsch P, Hijazi YM, Rosenberg SA, Marincola FM and Topalian SL: Comparative analysis of the in vivo expression of tyrosinase, Mart-1/Melan-a, and gp100 in metastatic melanoma lesions - implications for immunotherapy. J Immunother 21: 27-31, 1998.
    • (1998) J Immunother , vol.21 , pp. 27-31
    • Cormier, J.N.1    Abati, A.2    Fetsch, P.3    Hijazi, Y.M.4    Rosenberg, S.A.5    Marincola, F.M.6    Topalian, S.L.7
  • 31
    • 1842372075 scopus 로고    scopus 로고
    • Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
    • Jäger E, Ringhoffer M, Altmannsberger M, Arand M, Karbach J, Jäger D, Oesch F and Knuth A: Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer 71: 142-147, 1997.
    • (1997) Int J Cancer , vol.71 , pp. 142-147
    • Jäger, E.1    Ringhoffer, M.2    Altmannsberger, M.3    Arand, M.4    Karbach, J.5    Jäger, D.6    Oesch, F.7    Knuth, A.8
  • 33
    • 0031660839 scopus 로고    scopus 로고
    • Higher frequency of selective losses of HLA-A and -B allospecificities in metastases than in primary melanoma lesions
    • Geertsen R, Hofbauer G, Yue F-Y, Burg G and Dummer R: Higher frequency of selective losses of HLA-A and -B allospecificities in metastases than in primary melanoma lesions. J Invest Dermatol 111: 497-502, 1998.
    • (1998) J Invest Dermatol , vol.111 , pp. 497-502
    • Geertsen, R.1    Hofbauer, G.2    Yue, F.-Y.3    Burg, G.4    Dummer, R.5
  • 34
    • 0029095658 scopus 로고
    • C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically
    • Griffioen M, Peltenburg LT, van Oorschot DA and Schrier PI: C-myc represses transiently transfected HLA class I promoter sequences not locus-specifically. Immunobiolocy 193: 238-247, 1995.
    • (1995) Immunobiolocy , vol.193 , pp. 238-247
    • Griffioen, M.1    Peltenburg, L.T.2    Van Oorschot, D.A.3    Schrier, P.I.4
  • 35
    • 0030048081 scopus 로고    scopus 로고
    • A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes
    • Brichard VG, Herman J, van Pel A, Wildmann C, Gaugier B, Wolfel T, Boon T and Lethe B: A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol 26: 224-230, 1996.
    • (1996) Eur J Immunol , vol.26 , pp. 224-230
    • Brichard, V.G.1    Herman, J.2    Van Pel, A.3    Wildmann, C.4    Gaugier, B.5    Wolfel, T.6    Boon, T.7    Lethe, B.8
  • 38
    • 0028358609 scopus 로고
    • The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes
    • Liischer U, Filgueira L, Juretic A, Zuber M, Lüscher NJ, Heberer M and Spagnoli GC: The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int J Cancer 57: 612-619, 1994.
    • (1994) Int J Cancer , vol.57 , pp. 612-619
    • Liischer, U.1    Filgueira, L.2    Juretic, A.3    Zuber, M.4    Lüscher, N.J.5    Heberer, M.6    Spagnoli, G.C.7
  • 39
    • 0029997742 scopus 로고    scopus 로고
    • Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
    • Jaeger E, Bernhard H, Romero P, Ringhoffer M, Arand M, Karbach J, Ilsemann C, Hagedorn M and Knuth A: Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 66: 162-169, 1996.
    • (1996) Int J Cancer , vol.66 , pp. 162-169
    • Jaeger, E.1    Bernhard, H.2    Romero, P.3    Ringhoffer, M.4    Arand, M.5    Karbach, J.6    Ilsemann, C.7    Hagedorn, M.8    Knuth, A.9
  • 41
    • 0030248766 scopus 로고    scopus 로고
    • Peptide antigen production by the proteasome: Complexity provides efficiency
    • Groettrup M, Soza A, Kuckelkorn U and Kloetzel PM: Peptide antigen production by the proteasome: complexity provides efficiency. Immunol Today 17: 429-435, 1996.
    • (1996) Immunol Today , vol.17 , pp. 429-435
    • Groettrup, M.1    Soza, A.2    Kuckelkorn, U.3    Kloetzel, P.M.4
  • 42
    • 0026600786 scopus 로고
    • Subunit stoichiometry and three-dimensional arrangement in proteasomes from Thermoplasma acidophihun
    • Puhler G, Weinkauf S, Bachmann L, Muller S, Engel A, Hegerl R and Baumeister W: Subunit stoichiometry and three-dimensional arrangement in proteasomes from Thermoplasma acidophihun. EMBO J 11: 1607-1616, 1992.
    • (1992) EMBO J , vol.11 , pp. 1607-1616
    • Puhler, G.1    Weinkauf, S.2    Bachmann, L.3    Muller, S.4    Engel, A.5    Hegerl, R.6    Baumeister, W.7
  • 43
    • 0027392566 scopus 로고
    • Evidence indicating that the human proteasome is a complex dimer
    • Kopp F, Dahlmann B and Hendil KB: Evidence indicating that the human proteasome is a complex dimer. J Mol Biol 229: 14-19, 1993.
    • (1993) J Mol Biol , vol.229 , pp. 14-19
    • Kopp, F.1    Dahlmann, B.2    Hendil, K.B.3
  • 44
    • 0025886546 scopus 로고
    • Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes
    • Brown MG, Driscoll J and Monaco JJ: Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353: 355-357, 1991.
    • (1991) Nature , vol.353 , pp. 355-357
    • Brown, M.G.1    Driscoll, J.2    Monaco, J.J.3
  • 46
    • 0027223877 scopus 로고
    • MHC-linkcd LMP gene products specifically alter peptidase activities of the proteasome
    • Driscoll J, Brown MG, Finley D and Monaco JJ: MHC-linkcd LMP gene products specifically alter peptidase activities of the proteasome. Nature 365: 262-264, 1993.
    • (1993) Nature , vol.365 , pp. 262-264
    • Driscoll, J.1    Brown, M.G.2    Finley, D.3    Monaco, J.J.4
  • 47
    • 0025751612 scopus 로고
    • Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II recion
    • Bahram S, Arnold D, Brcsnahan M, Strominger JL and Spies T: Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II recion. Proc Natl Acad Sci USA 88: 10094-10098, 1991.
    • (1991) Proc Natl Acad Sci USA , vol.88 , pp. 10094-10098
    • Bahram, S.1    Arnold, D.2    Brcsnahan, M.3    Strominger, J.L.4    Spies, T.5
  • 48
    • 0026602751 scopus 로고
    • Allelic variants of the human putative peptide transporter involved in antigen processing
    • Colonna M, Bresnahan M, Bahram S, Strominger JL and Spies T: Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA 89: 3932-3936, 1992.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 3932-3936
    • Colonna, M.1    Bresnahan, M.2    Bahram, S.3    Strominger, J.L.4    Spies, T.5
  • 49
    • 0025604835 scopus 로고
    • A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway
    • Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D and De Mars R: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348: 744-747, 1990.
    • (1990) Nature , vol.348 , pp. 744-747
    • Spies, T.1    Bresnahan, M.2    Bahram, S.3    Arnold, D.4    Blanck, G.5    Mellins, E.6    Pious, D.7    De Mars, R.8
  • 50
    • 0027548728 scopus 로고
    • The transporters associated with antigen presentation
    • Townsend A and Trowsdale J: The transporters associated with antigen presentation. Semin Cell Biol 4: 53-61, 1993.
    • (1993) Semin Cell Biol , vol.4 , pp. 53-61
    • Townsend, A.1    Trowsdale, J.2
  • 51
    • 0028318838 scopus 로고
    • Downregulation of peptide transporter genes in cell lines transformed with the hichly oncogenic adenovirus 12
    • Rotem Yehudar R, Winograd S, Sela S, Coligan JE and Ehrlich R: Downregulation of peptide transporter genes in cell lines transformed with the hichly oncogenic adenovirus 12. J Exp Med 180: 477-488, 1994.
    • (1994) J Exp Med , vol.180 , pp. 477-488
    • Rotem Yehudar, R.1    Winograd, S.2    Sela, S.3    Coligan, J.E.4    Ehrlich, R.5
  • 53
    • 0028094647 scopus 로고
    • Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer
    • Kaklamanis L, Townsend A, Doussis Anagnostopoulou IA, Mortensen N, Harris AL and Gatter KC: Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am J Pathol 145: 505-509, 1994.
    • (1994) Am J Pathol , vol.145 , pp. 505-509
    • Kaklamanis, L.1    Townsend, A.2    Doussis Anagnostopoulou, I.A.3    Mortensen, N.4    Harris, A.L.5    Gatter, K.C.6
  • 54
    • 0028789344 scopus 로고
    • Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer
    • Kaklamanis L, Leek R, Koukourakis M, Gatter KC and Harris AL: Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res 55: 5191-5194, 1995.
    • (1995) Cancer Res , vol.55 , pp. 5191-5194
    • Kaklamanis, L.1    Leek, R.2    Koukourakis, M.3    Gatter, K.C.4    Harris, A.L.5
  • 55
    • 0029794179 scopus 로고    scopus 로고
    • Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing
    • Hicklin DJ, Kageshita T and Ferrone S: Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing. Tissue Antigens 48: 38-46, 1996.
    • (1996) Tissue Antigens , vol.48 , pp. 38-46
    • Hicklin, D.J.1    Kageshita, T.2    Ferrone, S.3
  • 58
    • 0029085917 scopus 로고
    • A new family of genes coding for an antigen recoenized by autolocous cytolytic T lymphocytes on a human melanoma
    • Van den Eynde B, Peelers O, De Backer O, Gaugier B, Lucas S and Boon T: A new family of genes coding for an antigen recoenized by autolocous cytolytic T lymphocytes on a human melanoma. J Exp Med 182: 689-698, 1995.
    • (1995) J Exp Med , vol.182 , pp. 689-698
    • Van Den Eynde, B.1    Peelers, O.2    De Backer, O.3    Gaugier, B.4    Lucas, S.5    Boon, T.6
  • 59
    • 2642683198 scopus 로고    scopus 로고
    • Simultaneous humoral and cellular immune response against cancer-testis antigen Ny-Eso-1 - Definition of human histocompatibility leukocyte antieen (Hla)-A2-bindins: Peptide epitopcs
    • Jaeger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ and Knuth A: Simultaneous humoral and cellular immune response against cancer-testis antigen Ny-Eso-1 - definition of human histocompatibility leukocyte antieen (Hla)-A2-bindins: peptide epitopcs. J Exp Med 187: 265-270; 1998.
    • (1998) J Exp Med , vol.187 , pp. 265-270
    • Jaeger, E.1    Chen, Y.T.2    Drijfhout, J.W.3    Karbach, J.4    Ringhoffer, M.5    Jager, D.6    Arand, M.7    Wada, H.8    Noguchi, Y.9    Stockert, E.10    Old, L.J.11    Knuth, A.12
  • 61
    • 0031688307 scopus 로고    scopus 로고
    • Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA
    • Hofbauer G, Dummer R, Laine E and Burg G: Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA. Arch Dermatol Res 290: 458-461, 1998.
    • (1998) Arch Dermatol Res , vol.290 , pp. 458-461
    • Hofbauer, G.1    Dummer, R.2    Laine, E.3    Burg, G.4
  • 64
    • 0028906594 scopus 로고
    • Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes
    • (published erratum appears in J Exp Med 181: 1261, 1995).
    • Wang RF, Robbins PF, Kawakami Y, Kang XQ and Rosenberg SA: Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes (published erratum appears in J Exp Med 181: 1261, 1995). J Exp Med 181:799-804, 1995.
    • (1995) J Exp Med , vol.181 , pp. 799-804
    • Wang, R.F.1    Robbins, P.F.2    Kawakami, Y.3    Kang, X.Q.4    Rosenberg, S.A.5
  • 66
    • 0029114633 scopus 로고
    • Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
    • Chen YT, Stocken E, Tsang S, Coplan KA and Old LJ: Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 92: 8125-8129, 1995.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 8125-8129
    • Chen, Y.T.1    Stocken, E.2    Tsang, S.3    Coplan, K.A.4    Old, L.J.5
  • 67
    • 0031956632 scopus 로고    scopus 로고
    • Tyrosinase immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: Frequency and distribution
    • Hofbauer G, Kamarashcv J, Gecrtsen R, Böni R and Dummer R: Tyrosinase immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. J Cutan Pathol 25: 204-209, 1998.
    • (1998) J Cutan Pathol , vol.25 , pp. 204-209
    • Hofbauer, G.1    Kamarashcv, J.2    Gecrtsen, R.3    Böni, R.4    Dummer, R.5
  • 68
    • 0031659143 scopus 로고    scopus 로고
    • MelanA/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: Frequency and distribution
    • Hofbauer G, Kamarashcv J, Gcertsen R, Böni R and Dummer R: MelanA/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Melanoma Res 8: 337-343, 1998.
    • (1998) Melanoma Res , vol.8 , pp. 337-343
    • Hofbauer, G.1    Kamarashcv, J.2    Gcertsen, R.3    Böni, R.4    Dummer, R.5
  • 71
    • 0032549042 scopus 로고    scopus 로고
    • Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type
    • Akslen LA, Monstad SE, Larsen B, Straume O and Ogreid D: Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Int J Cancer 79: 91-95, 1998.
    • (1998) Int J Cancer , vol.79 , pp. 91-95
    • Akslen, L.A.1    Monstad, S.E.2    Larsen, B.3    Straume, O.4    Ogreid, D.5
  • 72
    • 0031905632 scopus 로고    scopus 로고
    • Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas
    • Gnjatic S, Cai Z, Viguier M, Chouaib S, Guillet JG and Choppin J: Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J Immunol 160: 328-333, 1998.
    • (1998) J Immunol , vol.160 , pp. 328-333
    • Gnjatic, S.1    Cai, Z.2    Viguier, M.3    Chouaib, S.4    Guillet, J.G.5    Choppin, J.6
  • 73
    • 0030800823 scopus 로고    scopus 로고
    • A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma
    • Mandruzzato S, Brasseur F, Andry G, Boon T and van der Bruggen P: A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 186: 785-793, 1997.
    • (1997) J Exp Med , vol.186 , pp. 785-793
    • Mandruzzato, S.1    Brasseur, F.2    Andry, G.3    Boon, T.4    Van Der Bruggen, P.5
  • 74
    • 0030633566 scopus 로고    scopus 로고
    • HER-2/neu protein: A target for antigen-specific immunotherapy of human cancer
    • Disis ML and Cheever MA: HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. Adv Cancer Res 71: 343-371, 1997.
    • (1997) Adv Cancer Res , vol.71 , pp. 343-371
    • Disis, M.L.1    Cheever, M.A.2
  • 80
    • 0027942023 scopus 로고
    • Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity
    • Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ and Nadler LM: Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood 84: 3261-3282, 1994.
    • (1994) Blood , vol.84 , pp. 3261-3282
    • Guinan, E.C.1    Gribben, J.G.2    Boussiotis, V.A.3    Freeman, G.J.4    Nadler, L.M.5
  • 81
    • 0031463526 scopus 로고    scopus 로고
    • Is Ctla-4 a necative regulator for T-cell activation
    • Liu Y: Is Ctla-4 a necative regulator for T-cell activation. Immunol Today 18:569-572, 1997.
    • (1997) Immunol Today , vol.18 , pp. 569-572
    • Liu, Y.1
  • 82
    • 0028223557 scopus 로고
    • T-helper- And accessory-cell-independent cytotoxic responses to human tumor cells transfectcd with a B7 retroviral vector
    • Duhring C, Angman L, Spagnoli G and Lanzavecchia A: T-helper- and accessory-cell-independent cytotoxic responses to human tumor cells transfectcd with a B7 retroviral vector. Int J Cancer 57: 754-759, 1994.
    • (1994) Int J Cancer , vol.57 , pp. 754-759
    • Duhring, C.1    Angman, L.2    Spagnoli, G.3    Lanzavecchia, A.4
  • 83
    • 0028646191 scopus 로고
    • Specificity and longevity of antitumor immune responses induced by B7-transfected tumors
    • Townsend SE, Su FW, Atherton JM and Allison JP: Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 54: 6477-6483, 1994.
    • (1994) Cancer Res , vol.54 , pp. 6477-6483
    • Townsend, S.E.1    Su, F.W.2    Atherton, J.M.3    Allison, J.P.4
  • 84
    • 0028263666 scopus 로고
    • + T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma
    • + T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J Immunol 153: 421-428, 1994.
    • (1994) J Immunol , vol.153 , pp. 421-428
    • Li, Y.1    McGowan, P.2    Hellstrom, I.3    Hellstrom, K.E.4    Chen, L.5
  • 85
    • 0029165133 scopus 로고
    • In situ expression of B7 and CD28 receptor families in human malignant melanomarelevance for T-cell-mediated anti-tumor immunity
    • Denfeld RW, Dietrich A, Wuttig C, Tanczos E, Weiss JM, Vanscheidt W, Schopf E and Simon JC: In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Int J Cancer 62: 259-265, 1995.
    • (1995) Int J Cancer , vol.62 , pp. 259-265
    • Denfeld, R.W.1    Dietrich, A.2    Wuttig, C.3    Tanczos, E.4    Weiss, J.M.5    Vanscheidt, W.6    Schopf, E.7    Simon, J.C.8
  • 86
    • 0029032151 scopus 로고
    • A phase I trial of B7-transfected parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401
    • Fenton RT, Sznol M, Luster DG, Taub DD and Longo DL: A phase I trial of B7-transfected parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401. Hum Gene Ther 6: 87-106, 1995.
    • (1995) Hum Gene Ther , vol.6 , pp. 87-106
    • Fenton, R.T.1    Sznol, M.2    Luster, D.G.3    Taub, D.D.4    Longo, D.L.5
  • 87
    • 0031942907 scopus 로고    scopus 로고
    • Immune stimulatory potential of B7-1 and B7-2 retrovirally transduced melanoma cells: Suppression by IL-10
    • Dummer R, Yue F-Y, Pavlovic J, Geertscn R, Döring C, Moelling K and Burg G: Immune stimulatory potential of B7-1 and B7-2 retrovirally transduced melanoma cells: suppression by IL-10. Br J Cancer 77: 1413-1419, 1998.
    • (1998) Br J Cancer , vol.77 , pp. 1413-1419
    • Dummer, R.1    Yue, F.-Y.2    Pavlovic, J.3    Geertscn, R.4    Döring, C.5    Moelling, K.6    Burg, G.7
  • 88
    • 0028853546 scopus 로고
    • A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and alloseneic lymphocytes
    • Sule-Suso J, Arienti F, Melani C, Colombo MP and Parmiani G: A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and alloseneic lymphocytes. Eur J Immunol 25: 2737-2742, 1995.
    • (1995) Eur J Immunol , vol.25 , pp. 2737-2742
    • Sule-Suso, J.1    Arienti, F.2    Melani, C.3    Colombo, M.P.4    Parmiani, G.5
  • 89
    • 0028949152 scopus 로고
    • B7-1 and B7-2 costimulatory molecules activate differentially theTh1/Th2 developmental pathways: Application to autoimmune disease therapy
    • Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N and Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially theTh1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718, 1995.
    • (1995) Cell , vol.80 , pp. 707-718
    • Kuchroo, V.K.1    Das, M.P.2    Brown, J.A.3    Ranger, A.M.4    Zamvil, S.S.5    Sobel, R.A.6    Weiner, H.L.7    Nabavi, N.8    Glimcher, L.H.9
  • 90
    • 0028819315 scopus 로고
    • CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL
    • Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D and Azuma M: CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154: 97-105, 1995.
    • (1995) J Immunol , vol.154 , pp. 97-105
    • Lanier, L.L.1    O'Fallon, S.2    Somoza, C.3    Phillips, J.H.4    Linsley, P.S.5    Okumura, K.6    Ito, D.7    Azuma, M.8
  • 91
    • 0029201083 scopus 로고
    • Lymphocyte-melanoma interaction: Role of surface molecules
    • Becker JC and Bröcker EB: Lymphocyte-melanoma interaction: role of surface molecules. Recent Results Cancer Res 139: 205-214, 1995.
    • (1995) Recent Results Cancer Res , vol.139 , pp. 205-214
    • Becker, J.C.1    Bröcker, E.B.2
  • 93
    • 0026322355 scopus 로고
    • Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gammruand tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity
    • Becker JC, Dummer R, Hartmann AA, Burg G and Schmidt RE: Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gammruand tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 147: 4398-4401, 1991.
    • (1991) J Immunol , vol.147 , pp. 4398-4401
    • Becker, J.C.1    Dummer, R.2    Hartmann, A.A.3    Burg, G.4    Schmidt, R.E.5
  • 94
    • 0028236075 scopus 로고
    • Various cytokines modulate ICAM-1 shedding from melanoma and CTCL-derived cell lines: Inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma
    • Dummer R, Sigg-Zemann S, Kaltoft K, Muletta S, Meyer J and Burg G: Various cytokines modulate ICAM-1 shedding from melanoma and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma. Dermatology 189: 120-124, 1994.
    • (1994) Dermatology , vol.189 , pp. 120-124
    • Dummer, R.1    Sigg-Zemann, S.2    Kaltoft, K.3    Muletta, S.4    Meyer, J.5    Burg, G.6
  • 95
    • 0030790353 scopus 로고    scopus 로고
    • High CD44 surface expression on primary tumours of malicnant melanoma correlates with increased mctastatic risk and reduced survival
    • Dietrich A, Tanczos E, Vanscheidt W, Schopf E and Simon JC: High CD44 surface expression on primary tumours of malicnant melanoma correlates with increased mctastatic risk and reduced survival. Eur J Cancer 33: 926-930, 1997.
    • (1997) Eur J Cancer , vol.33 , pp. 926-930
    • Dietrich, A.1    Tanczos, E.2    Vanscheidt, W.3    Schopf, E.4    Simon, J.C.5
  • 96
    • 0030030109 scopus 로고    scopus 로고
    • Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage
    • Schadendorf D, Diehl S, Zuberbie T, Schadendorf C and Henz BM: Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology 192: 89-93, 1996.
    • (1996) Dermatology , vol.192 , pp. 89-93
    • Schadendorf, D.1    Diehl, S.2    Zuberbie, T.3    Schadendorf, C.4    Henz, B.M.5
  • 97
    • 0030910463 scopus 로고    scopus 로고
    • Endothelial-selectin ligands sialyl Lcwis(x) and sialyl Lcwis(a) are differentiation antigens immunogcnic in human melanoma
    • Ravindranath MH, Amiri AA, Bauer PM, Kelley MC, Essner R and Morion DL: Endothelial-selectin ligands sialyl Lcwis(x) and sialyl Lcwis(a) are differentiation antigens immunogcnic in human melanoma. Cancer 79: 1686-1697, 1997.
    • (1997) Cancer , vol.79 , pp. 1686-1697
    • Ravindranath, M.H.1    Amiri, A.A.2    Bauer, P.M.3    Kelley, M.C.4    Essner, R.5    Morion, D.L.6
  • 98
    • 0024408824 scopus 로고
    • Two types of mouse T-hclper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
    • Fiorentino DF, Bond MW and Mosmann TR: Two types of mouse T-hclper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095, 1989.
    • (1989) J Exp Med , vol.170 , pp. 2081-2095
    • Fiorentino, D.F.1    Bond, M.W.2    Mosmann, T.R.3
  • 99
    • 0026570853 scopus 로고
    • IL-10 inhibits human T cell proliferation and IL-2 production
    • Taga K and Tosato G: IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148: 1143-1148, 1992.
    • (1992) J Immunol , vol.148 , pp. 1143-1148
    • Taga, K.1    Tosato, G.2
  • 101
    • 0026721289 scopus 로고
    • Identification and induction of keratinocyte-dcrived IL-10
    • Enk AH and Katz SI: Identification and induction of keratinocyte-dcrived IL-10. J Immunol 149: 92-95, 1992.
    • (1992) J Immunol , vol.149 , pp. 92-95
    • Enk, A.H.1    Katz, S.I.2
  • 103
  • 104
    • 0030950036 scopus 로고    scopus 로고
    • Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules
    • Yue FY, Dummer R, Geertsen R, Hofbauer G, Laine E, Manolio S and Burg G: Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 71: 630-637, 1997.
    • (1997) Int J Cancer , vol.71 , pp. 630-637
    • Yue, F.Y.1    Dummer, R.2    Geertsen, R.3    Hofbauer, G.4    Laine, E.5    Manolio, S.6    Burg, G.7
  • 105
    • 0029888382 scopus 로고    scopus 로고
    • Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions
    • Dummer W, Bastian BC, Ernst N, Schänzle C, Schwaaf A and Bröcker EB: Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int J Cancer 66: 607-610, 1996.
    • (1996) Int J Cancer , vol.66 , pp. 607-610
    • Dummer, W.1    Bastian, B.C.2    Ernst, N.3    Schänzle, C.4    Schwaaf, A.5    Bröcker, E.B.6
  • 106
    • 0027232788 scopus 로고
    • + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
    • + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765, 1993.
    • (1993) J Immunol , vol.150 , pp. 4754-4765
    • De Waal Malefyt, R.1    Yssel, H.2    De, V.J.3
  • 107
    • 0027959417 scopus 로고
    • Interleukin 10 pretreatmcnt protects target cells from tumor- And allo-specific cytotoxic T cells and downregulates HLA class I expression
    • Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG and Kicssling R: Interleukin 10 pretreatmcnt protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371-2376, 1994.
    • (1994) J Exp Med , vol.180 , pp. 2371-2376
    • Matsuda, M.1    Salazar, F.2    Petersson, M.3    Masucci, G.4    Hansson, J.5    Pisa, P.6    Zhang, Q.J.7    Masucci, M.G.8    Kicssling, R.9
  • 108
    • 0008934205 scopus 로고    scopus 로고
    • Pathways to programmed cell death: Apoptosis and the skin
    • Haake AR and Polakowska RR: Pathways to programmed cell death: apoptosis and the skin. Curr Opin Dermatol 4: 247-255, 1997.
    • (1997) Curr Opin Dermatol , vol.4 , pp. 247-255
    • Haake, A.R.1    Polakowska, R.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.